The Royal College of Radiologists (RCR) has approximately 7,500 members and Fellows worldwide representing the disciplines of clinical oncology and clinical radiology. All members and Fellows of the College are registered medical or dental practitioners. The role of the College is to advance the science and practice of radiology and oncology, further public education and promote study and research through setting professional standards of practice. The College is a charity registered with the Charity Commission (no. 211540). The College is responsible for setting the curriculum for its two specialties to ensure that high educational standards are met in the interests of safe and responsible practice, assessment of schemes for training in the specialties of clinical radiology and clinical oncology and defining and monitoring programmes of education and training for clinical radiologists and clinical oncologists at all stages of their careers. Other activities include encouraging members to keep up to date in advances in their specialty by organising programmes of continuing professional development (CPD), awarding prizes and scholarships, and funding travelling professorships and lectureships and acting as a major provider of education for clinical radiologists and clinical oncologists through lectures, conferences and seminars.
ABOUT CLINICAL ONCOLOGY
Clinical Oncology, one of the official Journals of The Royal College of Radiologists (RCR), publishes all aspects of the clinical management of cancer patients, reflecting a multidisciplinary approach to therapy. Papers, editorials and reviews are published on all types of malignant disease embracing, pathology, diagnosis and treatment, including radiotherapy, chemotherapy, surgery, combined modality treatment and palliative care. Research and review papers covering epidemiology, radiobiology, radiation physics, tumour biology, and immunology are also published, together with letters to the editor, case reports and book reviews. Clinical Oncology is for all those with an active interest in the treatment of cancer.
Full-text articles are available from Volume 1, Issue 1 (1989) to the present. Access to abstracts is complimentary. Access to full text is limited to print subscribers. Register or login to: